10 employees
Orpha Biotech develops small molecules for the treatment of systemic sclerosis and juvenile rheumatoid arthritis.
$284K
from 1 investors over 1 rounds
Orpha Biotech Srl raised $284K on September 1, 2020
Investors: CDP Equity